xodcode
3 minutes ago
Approved Alz drug worth $20 billion mkt cap, current market cap just over $1 billion
Yes, not many stocks available offering a more favorable risk/reward ratio than AVXL. AVXL will be multiples of today's $13 price when approved by EMA, which could happen as early as July!